Retrospective Study
Copyright ©The Author(s) 2021.
World J Crit Care Med. Jul 9, 2021; 10(4): 120-131
Published online Jul 9, 2021. doi: 10.5492/wjccm.v10.i4.120
Table 1 Basal and laboratory features of the inserted catheters
Catheter area inserted

All patients, n = 1042, mean ± SD
Jugular, n = 743, mean ± SD
Subclavian, n = 155, mean ± SD
Femoral, n = 144, mean ± SD
P value
Baseline characteristics
Age, yr60.99 ± 19.8560.74 ± 20.2059.66 ± 19.1763.67 ± 18.570.939
Sex, female/male423/619339/44942/11242/580.009
Hospitalization time11.89 ± 16.3812.50 ± 16.0311.00 ± 20.089.73 ± 13.390.040
Laboratory finding
Biochemistry
BS, mg/dL139.45 ± 101.56145.21 ± 112.63120.35 ± 55.74130.30 ± 72.490.008
BUN, mg/dL42.77 ± 41.2951.11 ± 44.4019.65 ± 13.9124.58 ± 26.420.001
Creatinine, mg/dL2.62 ± 2.893.20 ± 3.140.99 ± 0.681.37 ± 1.680.001
TBIL, mg/dL0.87 ± 0.840.82 ± 0.630.80 ± 0.881.22 ± 1.430.485
AST, mg/dL37.65 ± 47.2232.56 ± 25.6040.04 ± 60.0561.38 ± 90.770.508
ALT, mg/dL35.81 ± 49.3730.31 ± 26.1838.58 ± 67.5961.21 ± 91.950.710
ALP, mg/dL108.57 ± 64.10104.95 ± 56.71104.66 ± 59.33131.48 ± 93.900.569
Na, mmol/L138.61 ± 5.38138.68 ± 5.33138.22 ± 5.07138.68 ± 5.960.125
K, mmol/L5.00 ± 1.035.13 ± 1.105.07 ± 0.714.79 ± 0.700.027
Cl, mmol/L100.23 ± 6.23100.18 ± 6.11100.41 ± 6.95100.29 ± 6.040.778
Amylase89.98 ± 49.8887.93 ± 47.6691.64 ± 53.2598.78 ± 56.300.419
CRP, mg/dL4.44 ± 8.123.53 ± 5.144.32 ± 7.659.26 ± 15.900.925
Hemogram
WBC, × 103/UL10.57 ± 4.5110.26 ± 3.5910.32 ± 4.0512.49 ± 7.720.228
Hb, g/dL13.77 ± 2.0713.63 ± 2.1214.09 ± 1.7714.16 ± 1.980.017
Hct, %42.17 ± 6.6242.07 ± 6.7842.23 ± 5.8042.62 ± 6.650.737
MCV, fL87.74 ± 6.2987.71 ± 6.4287.45 ± 6.1888.24 ± 5.700.927
MCH, pg29.37 ± 2.3629.30 ± 2.4129.48 ± 2.2929.67 ± 2.200.905
MCHC, g/dL33.25 ± 1.3633.19 ± 1.3733.47 ± 1.2933.29 ± 1.360.002
RDW, %14.69 ± 1.7314.74 ± 1.7914.45 ± 1.5014.66 ± 1.610.082
PLT, × 103/µL248.22 ± 80.14248.71 ± 76.33256.88 ± 76.01236.42 ± 100.380.073
MPV, fL8.48 ± 1.018.54 ± 1.038.33 ± 1.068.34 ± 0.860.085
Table 2 Analysis of the inserted catheter area according to gender, complication, and final situation

Catheter area inserted
Total, n (%)
P value

R jugular, n (%)
L jugular, n (%)
R subclavian, n (%)
L subclavian, n (%)
R femoral, n (%)
L femoral, n (%)
Gender
Female248 (42.0)73 (47.4)20 (29.4)23 (26.1)30 (39.0)29 (45.3)423 (40.6)0.009
Male343 (58.0)81 (52.6)48 (70.6)65 (73.9)47 (61.0)35 (54.7)619 (59.4)
Complication
No583 (98.6)149 (96.8)63 (92.6)75 (85.2)49 (63.6)46 (71.9)965 (92.6)0.001
Pntx001 (1.5)3 (3.4)004 (0.4)
GW00001 (1.3)1 (1.6)2 (0.2)
Bleeding2 (0.3)004 (4.5)1 (1.3)1 (1.6)8 (0.8)
WI2 (0.3)1 (0.6)1 (1.5)1 (1.1)2 (2.6)6 (9.4)13 (1.2)
AI4 (0.7)4 (2.6)2 (2.9)3 (3.4)11 (14.3)3 (4.7)27 (2.6)
Sepsis001 (1.5)2 (2.3)13 (16.9)7 (10.9)23 (2.2)
Decision
OPT104 (17.6)28 (18.2)12 (17.6)14 (15.9)9 (11.7)7 (10.7)174 (16.7)0.001
DWH484 (81.9)121 (78.6)46 (67.6)58 (63.6)35 (45.5)41 (64.1)783 (75.1)
Mortality3 (0.5)5 (3.2)10 (14.7)18 (20.5)33 (42.9)16 (25.0)85 (8.2)
Total591 (100)154 (100)68 (100)88 (100)77 (100)64 (100)1042 (100)
Table 3 Analysis of inserted catheter sites according to diseases
Diagnosis
Catheter area inserted
Total, n (%)
R jugular, n (%)
L jugular, n (%)
R subclavian, n (%)
L subclavian, n (%)
R femoral, n (%)
L femoral, n (%)
Renal diseases228 (38.5)43 (27.9)1 (1.5)2 (2.3)6 (7.8)5 (7.8)285 (27.3)
Respiratory diseases45 (7.6)8 (5.1)3 (4.4)3 (3.4)16 (20.8)6 (9.4)81 (7.8)
Endocrine diseases34 (5.8)7 (4.5)1 (1.5)04 (5.2)046 (4.4)
Multiple organ insufficiency001 (1.5)2 (2.3)12 (15.6)7 (10.9)22 (2.1)
Gastrointestinal system bleeding56 (9.5)12 (7.8)2 (2.9)003 (4.7)73 (7.0)
Gastrointestinal system perforations27 (4.6)2 (1.3)2 (2.9)05 (6.5)1 (1.6)37 (3.6)
Cerebrovascular diseases61 (10.3)16 (10.4)01 (1.1)4 (5.2)3 (4.7)85 (8.2)
Thoracic traumas1 (0.2)07 (10.3)14 (15.9)0022 (2.1)
Traffic accidents12 (2.0)7 (4.5)1 (1.5)2 (2.3)0022 (2.1)
Malignancies30 (5.1)7 (4.5)4 (5.9)1 (1.1)4 (5.2)4 (6.3)50 (4.8)
Firearm injury5 (0.8)3 (1.9)3 (4.4)4 (4.5)1 (1.3)1 (1.6)17 (1.6)
Cardiac diseases39 (6.6)22 (14.3)1 (1.5)1 (1.1)5 (6.5)13 (20.3)81 (7.8)
Cardiovascular diseases1 (0.2)2 (1.3)3 (4.4)3 (3.4)6 (7.8)015 (1.4)
Falls26 (4.4)15 (9.7)12 (17.6)7 (8.0)3 (3.9)6 (9.4)69 (6.6)
Burns22 (3.7)9 (5.8)18 (26.5)27 (30.7)8 (10.4)12 (18.8)96 (9.2)
Amputation1 (0.2)1 (0.6)02 (2.3)004 (0.4)
Penetrating tool injury3 (0.5)08 (11.8)11 (12.5)1 (1.3)1 (1.6)24 (2.3)
Cardiopulmonary resuscitation001 (1.5)8 (9.1)2 (2.6)2 (3.1)13 (1.2)
Total591 (100)154 (100)68 (100)88 (100)77 (100)64 (100)1042 (100)
Table 4 Analysis of the inserted catheter areas according to the services where the patients were hospitalized
Hospital services
Catheter area inserted
Total, n (%)
R jugular, n (%)
L jugular, n (%)
R subclavian, n (%)
L subclavian, n (%)
R femoral, n (%)
L femoral, n (%)
Emergency department94 (15.9)27 (17.5)12 (17.6)14 (15.9)10 (13.0)10 (15.6)167 (16)
Infectious diseases service11 (1.9)2 (1.3)1 (1.5)1 (1.1)3 (3.9)4 (6.3)22 (2.1)
General internal medicine service173 (29.3)45 (29.2)5 (7.4)1 (1.1)9 (11.7)8 (12.5)241 (23.1)
Nephrology service99 (16.8)21 (13.6)03 (3.4)7 (9.1)5 (7.8)135 (13)
Gastroenterology service29 (4.9)7 (4.5)0002 (3.1)38 (3.6)
Intensive care unit40 (6.8)10 (6.5)13 (19.1)17 (19.3)31 (40.3)20 (31.3)131 (12.6)
Cardiology service12 (2.0)3 (1.9)1 (1.5)2 (2.3)1 (1.3)1 (1.6)20 (1.9)
Brain surgery service24 (4.1)7 (4.5)5 (7.4)7 (8.0)2 (2.6)3 (4.7)48 (4.6)
Thoracic surgery service4 (0.7)4 (2.6)6 (8.8)13 (14.8)4 (5.2)2 (3.1)33 (3.2)
Chest diseases service18 (3.0)7 (4.5)01 (1.1)1 (1.3)1 (1.6)28 (2.7)
General surgery service46 (7.8)3 (1.9)8 (11.8)9 (10.2)7 (9.1)4 (6.3)77 (7.4)
Cardiovascular surgery service10 (1.7)07 (10.3)10 (11.4)1 (1.3)1 (1.6)29 (2.8)
Orthopedics and traumatology service10 (1.7)13 (8.4)10 (14.7)6 (6.8)02 (3.1)41 (3.9)
Plastic and reconstructive surgery service4 (0.7)2 (1.3)04 (4.5)01 (1.6)11 (1.1)
Neurology service17 (2.9)3 (1.9)001 (1.3)021 (2.0)
Total591 (100)154 (100)68 (100)88 (100)77 (100)64 (100)1042 (100)